Wilson Sonsini Goodrich & Rosati advised Seal Rock on the transaction.Seal Rock Therapeutics, Inc., a clinical stage company developing first-in-class and best-in-class kinase inhibitors, has announced…
Seal Rock Therapeutics’ Out-Licensing Agreement with GENFIT
